Advanced Oncotherapy Share Price (AVO)

38.00 0.00 (0.00%) delayed: 8:19AM BST
Bid price 36.00 Open price 0.00
Ask price 40.00 Prev close 38.00
High price 0.00 Spread 10.00%
Low price 0.00 Volume 0

Register now for FREE live Advanced Oncotherapy share prices, Advanced Oncotherapy stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Advanced Oncotherapy Level 2 Data, indepth research tools and investor commentary for Advanced Oncotherapy (AVO) and other London Stock Exchange equities.

Advanced Oncotherapy Share Price Chart

Advanced Charts >>

Register now for FREE Advanced Oncotherapy share price charts

Advanced Oncotherapy Share Price Information

Name Advanced Oncotherapy Epic AVO
Sector Health Care Equipment & Services ISIN GB00BD6SX109
Activites Advanced Oncotherapy plc (formerly CareCapital Group plc) is a provider of particle therapy with protons that harnesses the best in modern technology. Advanced Oncotherapy's team ADAM, based in Geneva, focuses on the development of a proprietary proton accelerator called Linac Image Guided Hadron Technology (LIGHT). LIGHT's compact configuration delivers proton beams in a way that facilitates greater precision and electronic control which is not achievable with older technologies. Advanced Oncotherapy will offer healthcare providers affordable systems that will enable them to treat cancer with an innovative technology as well as lower treatment related side effects. Advanced Oncotherapy continually monitors the market for any emerging improvements in delivering proton therapy and actively seeks working relationships with providers of these innovative technologies. Through these relationships, the Company will remain the prime provider of an innovative and cost-effective system for particle therapy with protons. Index n/a

Advanced Oncotherapy Key Numbers

Latest Share Price (p) 38.00 Net Gearing (%) 36.75
Market Capitalisation (£m) 64.44 Gross Gearing (%) 36.87
Shares in issue (m) 169.57 Debt Ratio 0.00
P/E Ratio -2.17 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.58
Dividend Yield (%) 0.00 Price to book value 2.25
Dividend cover (x) 0.00 ROCE (%) -57.54
Earning per share (p) -17.55 EPS Growth (%) -3.17
52 week high / low 63.50 / 26.00 DPS Growth (%) n/a

Advanced Oncotherapy Director Deals

Dec.Date Type Director Pos No. of Shares
12/01/2018 BUY Dr Enrico Vanni NED 40,000
01/08/2017 BUY Dr Enrico Vanni NED 100,000
15/05/2017 BUY Prof Steve Myers NED 400,000
11/05/2017 BUY Prof Christopher Nutting RES 202,500
26/04/2017 BUY Dr Mike Sinclair CH 200,000

More Advanced Oncotherapy Director Deals >>

Advanced Oncotherapy Company News

16:30 16/10/2018

Advanced Oncotherapy (AVO): Four components integrated

Hardman & Co Research Hardman & Co Research: Advanced Oncotherapy (AVO): Four components integrated 16-Oct-2018 / 16:30 GMT/BST Hardman & Co: Four components integrated AVO's goal is to deliver an affordable and novel proton therapy system (PT), based on state-of-the-art...

15:58 16/10/2018

Advanced Oncotherapy (AVO): Treatment planning system agreement

Hardman & Co Research Hardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement 16-Oct-2018 / 15:58 GMT/BST Hardman & Co: Four components integrated AVO's goal is to deliver an affordable and novel proton therapy system (PT), based on...

07:30 10/10/2018

GPSL Research - Flash Note on AVO

RNS Number : 5617D Advanced Oncotherapy PLC 10 October 2018   Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional...

More Advanced Oncotherapy Company News >>

Register now for FREE Advanced Oncotherapy company news

Advanced Oncotherapy Share Price Discussions

more than 1 year ago

final year results for Advanced Oncotherapy (AVO)

final year results for Advanced Oncotherapy: click here

Register now for FREE Advanced Oncotherapy share price discussions